What's the Problem?
Today there is a limited access to molecular diagnostics in developing countries. This limitation occurs because of high equipment investment and high costs of consumables. Also, a lack of local technical assistance for recognized brands doing molecular diagnostics limits the possibilities.
Leader companies need a high number of samples per platform use and have specific facilities requirements which make more difficult its implementation.